MIR3143

Across TCGA pan-cancer cohorts, MIR3143 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR3143’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR3143 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3143 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

BRCA, KIRC, and STAD are the cancer types where MIR3143 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3143 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.196	.002	4	view →
KIRC	All	All	+0.128	.021	3	view →
STAD	All	All	+0.448	.009	2	view →
LIHC	Male	All	+0.107	.039	2	view →
COAD	Male	II,III,IV	−0.332	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR3143–BRCA

Open the BRCA breakdown →